Search research articles
Contact Us
Filters
Showing results (51-60 of 337) with videos related to
Page
of 34
Sort By:
Nature
|
May 24, 2013
BAF complexes facilitate decatenation of DNA by topoisomerase IIα
Emily C Dykhuizen, Diana C Hargreaves, Erik L Miller, et al.
Plos One
|
January 19, 2019
Identification of CD24 as a marker of Patched1 deleted medulloblastoma-initiating neural progenitor cells
Jonathan P Robson, Marc Remke, Marcel Kool, et al.
Genes, Chromosomes & Cancer
|
April 25, 2021
Transposable element insertion as a mechanism of SMARCB1 inactivation in atypical teratoid/rhabdoid tumor
Christian Thomas, Kathrin Oehl-Huber, Susanne Bens, et al.
BMC Cancer
|
June 15, 2013
The histone deacetylase inhibitor SAHA acts in synergism with fenretinide and doxorubicin to control growth of rhabdoid tumor cells
Kornelius Kerl, David Ries, Rebecca Unland, et al.
Acta Neuropathologica
|
May 30, 2014
Genomic and transcriptomic analyses match medulloblastoma mouse models to their human counterparts
Julia Pöschl, Sebastian Stark, Philipp Neumann, et al.
Nature Communications
|
June 4, 2014
Identification of genes involved in the biology of atypical teratoid/rhabdoid tumours using Drosophila melanogaster
Astrid Jeibmann, Kristin Eikmeier, Anna Linge, et al.
Neuro-Oncology
|
March 30, 2019
EZHIP/CXorf67 mimics K27M mutated oncohistones and functions as an intrinsic inhibitor of PRC2 function in aggressive posterior fossa ependymoma
Jens-Martin Hübner, Torsten Müller, Dimitris N Papageorgiou, et al.
Plos One
|
April 23, 2015
Serpine2/PN-1 Is Required for Proliferative Expansion of Pre-Neoplastic Lesions and Malignant Progression to Medulloblastoma
Catherine Vaillant, Paola Valdivieso, Sandro Nuciforo, et al.
Neuro-Oncology
|
January 1, 2020
Molecular subgrouping of atypical teratoid/rhabdoid tumors-a reinvestigation and current consensus
Ben Ho, Pascal D Johann, Yura Grabovska, et al.
Acta Neuropathologica
|
June 7, 2024
Clinically unfavorable transcriptome subtypes of non-WNT/non-SHH medulloblastomas are associated with a predominance in proliferating and progenitor-like cell subpopulations
Konstantin Okonechnikov, Daniel Schrimpf, Jan Koster, et al.
Page
of 34
Search research articles
Search
Showing results (51-60 of 337) with videos related to
Sort By:
Page
of 34
Nature
|
May 24, 2013
BAF complexes facilitate decatenation of DNA by topoisomerase IIα
Emily C Dykhuizen, Diana C Hargreaves, Erik L Miller, et al.
Plos One
|
January 19, 2019
Identification of CD24 as a marker of Patched1 deleted medulloblastoma-initiating neural progenitor cells
Jonathan P Robson, Marc Remke, Marcel Kool, et al.
Genes, Chromosomes & Cancer
|
April 25, 2021
Transposable element insertion as a mechanism of SMARCB1 inactivation in atypical teratoid/rhabdoid tumor
Christian Thomas, Kathrin Oehl-Huber, Susanne Bens, et al.
BMC Cancer
|
June 15, 2013
The histone deacetylase inhibitor SAHA acts in synergism with fenretinide and doxorubicin to control growth of rhabdoid tumor cells
Kornelius Kerl, David Ries, Rebecca Unland, et al.
Acta Neuropathologica
|
May 30, 2014
Genomic and transcriptomic analyses match medulloblastoma mouse models to their human counterparts
Julia Pöschl, Sebastian Stark, Philipp Neumann, et al.
Nature Communications
|
June 4, 2014
Identification of genes involved in the biology of atypical teratoid/rhabdoid tumours using Drosophila melanogaster
Astrid Jeibmann, Kristin Eikmeier, Anna Linge, et al.
Neuro-Oncology
|
March 30, 2019
EZHIP/CXorf67 mimics K27M mutated oncohistones and functions as an intrinsic inhibitor of PRC2 function in aggressive posterior fossa ependymoma
Jens-Martin Hübner, Torsten Müller, Dimitris N Papageorgiou, et al.
Plos One
|
April 23, 2015
Serpine2/PN-1 Is Required for Proliferative Expansion of Pre-Neoplastic Lesions and Malignant Progression to Medulloblastoma
Catherine Vaillant, Paola Valdivieso, Sandro Nuciforo, et al.
Neuro-Oncology
|
January 1, 2020
Molecular subgrouping of atypical teratoid/rhabdoid tumors-a reinvestigation and current consensus
Ben Ho, Pascal D Johann, Yura Grabovska, et al.
Acta Neuropathologica
|
June 7, 2024
Clinically unfavorable transcriptome subtypes of non-WNT/non-SHH medulloblastomas are associated with a predominance in proliferating and progenitor-like cell subpopulations
Konstantin Okonechnikov, Daniel Schrimpf, Jan Koster, et al.
Page
of 34